Gregor Kosec – Head of Intellectual Property and Science


In addition to leading several industrial projects focusing on the development/improvement of genetic engineering/synthetic biology based production processes Gregor, is also heading the IP protection and scientific aspects of ACIES’s activities. His primary focus is pharmaceutical biotechnology, on the one hand generation of novel bioactive products and on the other hand new approaches for efficient production of mature high value products, particularly clinically well accepted generic pharmaceuticals. In recent years he is working on application of metabolic/biosynthetic engineering together with classical and directed mutagenesis to create new biotechnological solutions as well as on transfer of promising approaches from proof-of-concept to industrial environment.


Dušan Goranovič – Head of Microbiology

Dušan finished his undergraduate studies in Microbiology and later obtained his PhD in Biotechnology at the Biotechnical Faculty, University of Ljubljana. In the past 10 years, he has been working in the field of pharmaceutical biotechnology and has led collaborations of Acies Bio with pharmaceutical industry, focusing on strain improvement and bioprocess development. As head of Microbiology at Acies Bio, he is involved in development and advances of approaches used in microbial strain improvement, such as metabolic engineering, high-throughput testing, and bioprocess scale-up.


 This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 720793